Q1 2022 X4 Pharmaceuticals Inc Earnings Call Transcript
Greetings and welcome to X4 Pharmaceuticals' First Quarter 2022 Financial and Operating Results Conference Call. (Operator Instructions)
As a reminder, this conference call is being recorded.
It is now my pleasure to introduce your host Dr. Glenn Schulman, Head of Investor Relations. Please begin.
Thank you, operator. Good morning everyone. Presenting on today's call will be X4's Chief Executive Officer, Dr. Paula Ragan and the company's Chief Financial Officer, Adam Mostafa. Following prepared remarks by each, we will open the call to your questions, during which we'll also be joined by our Chief Scientific Officer, Art Taveras; Chief Medical Officer, Diego Cadavid; and Chief Operating Officer, Mary DiBiase.
As a reminder, on today's call X4 will be making forward-looking statements regarding regulatory and product development plans as well as research activities. These statements are subject to risks and uncertainties that may cause actual results to differ from those
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |